冠状动脉介入治疗期间冠状动脉内选择性给药糖蛋白IIb/IIIa抑制剂治疗COVID-19患者急性心肌梗死

Q4 Medicine

Kardiologiya i serdechno-sosudistaya khirurgiya Pub Date : 2022-01-01 DOI:10.17116/kardio202215021177

S. A. Korotkikh, O. Shcherbakova, O. Derbenev

{"title":"冠状动脉介入治疗期间冠状动脉内选择性给药糖蛋白IIb/IIIa抑制剂治疗COVID-19患者急性心肌梗死","authors":"S. A. Korotkikh, O. Shcherbakova, O. Derbenev","doi":"10.17116/kardio202215021177","DOIUrl":null,"url":null,"abstract":"To date, there are still no the targeted studies devoted to acute coronary syndrome or myocardial infarction in patients with COVID-19. The authors report selective intracoronary administration of glycoprotein IIb/IIIa inhibitor for acute myocardial infarction in a patient with COVID-19 during percutaneous coronary intervention. © 2022, Media Sphera Publishing Group. All rights reserved.","PeriodicalId":17701,"journal":{"name":"Kardiologiya i serdechno-sosudistaya khirurgiya","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Selective intracoronary administration of glycoprotein IIb/IIIa inhibitors for acute myocardial infarction in a patient with COVID-19 during percutaneous coronary intervention\",\"authors\":\"S. A. Korotkikh, O. Shcherbakova, O. Derbenev\",\"doi\":\"10.17116/kardio202215021177\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To date, there are still no the targeted studies devoted to acute coronary syndrome or myocardial infarction in patients with COVID-19. The authors report selective intracoronary administration of glycoprotein IIb/IIIa inhibitor for acute myocardial infarction in a patient with COVID-19 during percutaneous coronary intervention. © 2022, Media Sphera Publishing Group. All rights reserved.\",\"PeriodicalId\":17701,\"journal\":{\"name\":\"Kardiologiya i serdechno-sosudistaya khirurgiya\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kardiologiya i serdechno-sosudistaya khirurgiya\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17116/kardio202215021177\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kardiologiya i serdechno-sosudistaya khirurgiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/kardio202215021177","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Selective intracoronary administration of glycoprotein IIb/IIIa inhibitors for acute myocardial infarction in a patient with COVID-19 during percutaneous coronary intervention

To date, there are still no the targeted studies devoted to acute coronary syndrome or myocardial infarction in patients with COVID-19. The authors report selective intracoronary administration of glycoprotein IIb/IIIa inhibitor for acute myocardial infarction in a patient with COVID-19 during percutaneous coronary intervention. © 2022, Media Sphera Publishing Group. All rights reserved.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Kardiologiya i serdechno-sosudistaya khirurgiya Medicine-Surgery

CiteScore

0.80

自引率

0.00%

发文量